These scientific outcomes show that, like other chronic diseases,TB may cause psychiatric problems.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Objectives: This study aims to observe the health-related quality of life and depression and anxiety symptomsof newly diagnosed patients who were taking four-drug anti-tuberculosis (anti-TB) therapy during the treatment period.Methods: The TB-diagnosed patients who were taking four-drug TB therapy and suitable for this study werefollowed up during the treatment period in the providence of Eskişehir.
📊
Temel Bulgular & Veri:The patients were assessed accordingto the Short From-36 (SF-36) health quality, Beck depression, and Beck anxiety scales at three months and atthe end of this study (six months).Results: Significant improvements were observed in all SF-36 components at the end of this study (p< 0.001).When compared with the beginning and the end of the treatment, there was a statistically significant decreasein Beck depression and anxiety scores (p<0.001).Conclusion: Improvement in the patients’ Beck depression–anxiety and life quality scores without additionalpsychiatric treatment is an important finding.
💡
Sonuç & Katkı:These scientific outcomes show that, like other chronic diseases,TB may cause psychiatric problems.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Özet
Objectives: This study aims to observe the health-related quality of life and depression and anxiety symptomsof newly diagnosed patients who were taking four-drug anti-tuberculosis (anti-TB) therapy during the treatment period.Methods: The TB-diagnosed patients who were taking four-drug TB therapy and suitable for this study werefollowed up during the treatment period in the providence of Eskişehir. The patients were assessed accordingto the Short From-36 (SF-36) health quality, Beck depression, and Beck anxiety scales at three months and atthe end of this study (six months).Results: Significant improvements were observed in all SF-36 components at the end of this study (p< 0.001).When compared with the beginning and the end of the treatment, there was a statistically significant decreasein Beck depression and anxiety scores (p<0.001).Conclusion: Improvement in the patients’ Beck depression–anxiety and life quality scores without additionalpsychiatric treatment is an important finding. These scientific outcomes show that, like other chronic diseases,TB may cause psychiatric problems.
🔖
Bu Makaleye Atıf Yap
KURT, F., BİLGE, U., ÜNLÜOĞLU, İ., KÖŞGER, F., ÖZEN, H. (2020). The Effects of Tuberculosis Treatment on Quality of Life, Anxiety and Depression. The anatolian journal of family medicine (Online), Cilt: 3 - Sayı: 2, 96–100. https://ajindex.com/articles/365025
Mohajan HK. Tuberculosis is a fatal disease among some developing countries of the world. American Journal of Infectious Diseases and Microbiology 2015;3(1):18–31
Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008;134(4 Suppl):43S–56S
Moussas G, Tselebis A, Karkanias A, Stamouli D, Ilias I, Bratis D, et al. A comparative study of anxiety and depression in patients with bronchial asthma, chronic obstructive pulmonary disease and tuberculosis in a general hospital of chest diseases. Ann Gen Psychiatry 2008;7:7
Nault D, Borycki E, editors. Comprehensive Management of Chronic Obstructive Pulmonary Disease. Hamilton: BC Dekker Inc; 2002.p.215–44
Hansel NN, Wu AW, Chang B, Diette GB. Quality of Life in Tuberculosis: Patient and Provider Perspectives. Qual Life Res 2004;13(3):639–52
Baral SC, Aryal Y, Bhattrai R, King R, Newell JN. The importance of providing counselling and financial support to patients receiving treatment for multi-drugresistant TB: mixed method qualitative and pilot intervention studies. BMC Public Health 2014;14:46
Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30(6):473–83
Aydemir Ö. Konsültasyon-liyezon psikiyatrisinde yaşam kalitesi ölçümü: Kısa Form-36 (SF-36). 3 Psikiyatri Psikoloji Psikofarmakoloji (3P) Dergisi 1999;7(Ek 2):14–22
Koçyiğit H, Aydemir Ö, Ölmez N, Memiş A. SF-36’nın Türkçe için güvenilirliği ve geçerliliği. Ege Fizik Tedavi ve Rehabilitasyon Dergisi 1999
BECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–71
Hisli N. Beck Depresyon Envanterinin geçerliliği üzerine bir çalışma. Psikoloji Dergisi 1988;6:118–26
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety. J Consult Clin Psychol 1988;56(6):893– 7
Ulusoy M, Sahin NH, Erkmen H. Turkish version of the Beck Anxiety Inventory: Psychometric properties. Journal of Cognitive Psychotherapy 1998;12(2):163–72
Baral SC, Karki DK, Newell JN. Causes of stigma and discrimination associated with tuberculosis in Nepal: a qualitative study. BMC Public Health 200